Search

Search Constraints

You searched for: Author/Creator Cortez, Maria Angelica

Search Results

1. 396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side. (9th November 2020)

2. 396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side. (9th November 2020)

3. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity. Issue 1 (24th June 2020)

4. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. (September 2021)

5. Indoleamine 2, 3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells. (1st September 2018)

6. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy. (September 2020)

7. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. Issue 2 (26th October 2020)

8. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. Issue 2 (26th October 2020)

9. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. Issue 2 (26th October 2020)

10. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. Issue 2 (26th October 2020)